Abstract: Devices, systems, and methods for generating therapy annotations for display on a graphical user interface are disclosed herein. In some embodiments, therapy annotations can correspond to a location of a tip section of a catheter relative to an anatomical structure of a patient when therapy is delivered to the anatomical structure. One or more properties of the therapy annotations can be based at least in part on signals received from sensors distributed about the tip section of the catheter and/or on other characteristics of therapy delivery. The therapy annotations can be displayed alone or in combination with a three-dimensional surface representation of the anatomical structure, a representation of the catheter, and/or other visual indicia, such as a therapy contour, a distance from a nearest therapy site and/or the most recent therapy site, and/or a representation of gaps between two therapy sites.

Abstract: Methods are provided in which a network device hosts distinct network access resources that are managed by different entities. The method includes obtaining a request for partitioning one or more network resources of an on-premise network device for connecting one or more endpoints to a first network managed by a first entity. The on-premise network device connects one or more endpoints to a second network managed by a different entity. The method further involves partitioning, based on the request, the one or more network resources and connecting the one or more endpoints to the first network using the one or more network resources. The one or more network resources are managed by the first entity while at least one other network resource of the on-premise network device is managed by the different entity and is associated with connecting the one or more endpoints to the second network.

Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.

Abstract: Methods, systems and devices are provided which transmit energy to a body lumen or passageway in the form of pulsed electric fields (PEFs) and in a manner which provides focal therapy. In some embodiments, PEFs are delivered through independent electrically active electrodes of an energy delivery body, typically in a monopolar fashion. Such delivery concentrates the electrical energy over a smaller surface area, resulting in stronger effects than delivery through an electrode extending circumferentially around the lumen or passageway. It also forces the electrical energy to be delivered in a staged regional approach, mitigating the effect of preferential current pathways through the surrounding tissue. Focal delivery of PEFs can provide increased tissue lethality by employing precise timing and sequencing of energy delivery to the electrodes.

Abstract: A method of performing a black start in a wind farm is provided, the wind farm including a primary black start enabled wind turbine, at least one secondary black start enabled wind turbine, and a wind farm grid interconnecting at least a part of the wind turbines in the wind farm, the method including (a) starting the primary black start enabled wind turbine in black start mode in order to supply voltage to the wind farm grid, (b) monitoring, at the at least one secondary black start enabled wind turbine, an electric parameter value in the wind farm grid, and (c) starting the at least one secondary black start enabled wind turbine in black start mode in order to supply voltage to the wind farm grid when the monitored electric parameter value meets a predetermined condition. A corresponding wind farm is also provided.

Abstract: A communication system includes a passive quadrature generator connected directly to an in-phase (I) mixer and a quadrature (Q) mixer, an I LO amplitude detect circuit connected to the passive quadrature generator and connected to the I mixer, and a Q LO amplitude detect circuit connected to the passive quadrature generator and connected to the Q mixer, the I LO amplitude detect circuit configured to detect an I LO amplitude and the Q LO amplitude detect circuit configured to detect a Q LO amplitude, and a combining and integrating circuit configured to receive the detected I LO amplitude and the detected Q LO amplitude and generate an I LO DC bias voltage to bias the I mixer and a Q LO DC bias voltage to bias the Q mixer.

Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.

Abstract: Provided is a method of controlling a wind turbine or a wind park including at least one wind turbine connected to a utility grid for utility grid support, the method including: receiving a control command from a utility grid manager, and selectively controlling the wind turbine according to the control command.

Abstract: Provided is a method of controlling at least one converter of at least one wind turbine connectable to a wind park grid of a wind park during black start or island mode of the wind park, the method including: ramping up a converter voltage reference unless a power related condition and/or a wind park grid frequency related condition or a converter current related condition is violated.

Abstract: The present invention relates to compounds of formula (I), which are modulators of sortilin activity. The invention also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds in the treatment or prevention of medical conditions where modulation of sortilin activity is beneficial.

Abstract: A mobile device includes a panel audio loudspeaker including a display panel and an actuator coupled to the display panel. The mobile device includes a temperature sensor arranged to sense a temperature of the display panel, and an electronic control module in communication with the actuator and the temperature sensor. The electronic control module is programmed to perform operations including: obtaining, from the temperature sensor, data indicating a temperature of the display panel; and based on the data indicating the temperature of the display panel, adjusting a power signal provided to the actuator to drive the panel audio loudspeaker. The power signal can be adjusted by selecting, based on the data indicating the temperature of the display panel, a target temperature of the display panel; mapping the target temperature to a target power level; and changing the power signal provided to the actuator to the target power level.

Abstract: The present invention relates to compounds of formula (I), which are modulators of sortilin activity. The invention also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds in the treatment or prevention of medical conditions where modulation of sortilin activity is beneficial.

Abstract: Provided is a method of controlling a converter, in particular of a wind turbine, the converter including a first converter portion connected to a generator, a DC-link, and a second converter portion connected to a utility grid. The method including: controlling the first converter portion and the second converter portion by a first control signal and a second control signal, respectively, both being derived based on a requested power signal, in particular requested active power signal, and a generator rotational speed, wherein the first control signal indicates substantially constant generator torque for rotational speed variations of the generator rotational speed above a frequency threshold.

Abstract: A method of supplying power to an electrically isolated wind farm is provided including a plurality of wind turbines and a power generator. In a low wind condition, where a wind speed falls below a threshold value, active power and reactive power is supplied from the power generator to a first wind turbine and wind farm passive components. In a second operation mode after the first operation mode, active power is supplied from the power generator to the first wind turbine and a second wind turbine, and reactive power is supplied/consumed by the first wind turbine to the cables and transformers between it and the second wind turbine.

Abstract: An approach for managing workload deployment, specifically, restarting workloads that are interdependent is provided. The approach includes a mechanism by which a group of interdependent workloads in a cloud infrastructure environment can be restarted sequentially. Interdependent workloads simply mean workloads that depend on each other in some way such that if one goes down, then the cloud infrastructure environment can experience downtime. The workloads can be of the same or different types. Additionally, this mechanism can be scaled such that groups of workloads can be restarted simultaneously. Furthermore, the approach can accommodate cloud infrastructure environments with multiple types of workloads, and it allows for groups of workloads to be restarted simultaneously while also allowing the workloads within each group to be restarted sequentially.

Abstract: A method of performing a black start in a wind farm is provided, the wind farm including a primary black start enabled wind turbine, at least one secondary black start enabled wind turbine, and a wind farm grid interconnecting at least a part of the wind turbines in the wind farm, the method including (a) starting the primary black start enabled wind turbine in black start mode in order to supply voltage to the wind farm grid, (b) monitoring, at the at least one secondary black start enabled wind turbine, an electric parameter value in the wind farm grid, and (c) starting the at least one secondary black start enabled wind turbine in black start mode in order to supply voltage to the wind farm grid when the monitored electric parameter value meets a predetermined condition. A corresponding wind farm is also provided.

Abstract: The present invention relates to compounds of formula (I), which are modulators of sortilin activity. The invention also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds in the treatment or prevention of medical conditions where modulation of sortilin activity is beneficial.

Abstract: Aspects described herein include devices and methods for an envelope tracking power supply. In some aspects, the envelope tracking power supply includes an envelope signal input port, an output power port, an input interface circuit coupled to the envelope signal input port, sensing and conditioning circuitry, and amplifier circuitry coupled between the input interface circuit and the sensing and conditioning circuitry, the amplifier circuitry having one or more control inputs. The envelope tracking power supply additionally includes switcher circuitry coupled to the output of the sensing and conditioning circuitry, and the output power port, and the supply further includes output filter circuitry coupled to the output power port and machine learning circuitry configured to receive state tracking data for performance of a transmit power amplifier (PA) that receives power via the output power port.

Abstract: Aspects described herein include devices and methods for generating a supply voltage for a power amplifier. One aspect is an apparatus including a first amplifier and a second amplifier having a control input, where the control input of the second amplifier is configured to set a power state for the second amplifier. The apparatus has an input interface circuit coupled to the two amplifiers, sensing and conditioning circuitry coupled between the amplifier outputs and switcher circuitry, and output filter circuitry, where the output of the first amplifier is coupled to an output power port via the output filter circuitry, and where the output of the second amplifier is coupled to the output power port via the output filter circuitry.

Abstract: Energy is transmitted to a body lumen or passageway in the form of pulsed electric fields (PEFs) and in a manner which provides focal therapy. In some embodiments, PEFs are delivered through independent electrically active electrodes of an energy delivery body, typically in a monopolar fashion. Such delivery concentrates the electrical energy over a smaller surface area, resulting in stronger effects than delivery through an electrode extending circumferentially around the lumen or passageway. It also forces the electrical energy to be delivered in a staged regional approach, mitigating the effect of preferential current pathways through the surrounding tissue. Focal delivery of PEFs can provide increased tissue lethality by employing precise timing and sequencing of energy delivery to the electrodes.